false 0001179929 0001179929 2021-01-14 2021-01-14
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________
FORM 8-K
______________
Current Report
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 14, 2021 (January 14, 2021)
______________
MOLINA HEALTHCARE, INC.
(Exact name of registrant as specified in its charter)

Delaware | 001-31719 | 13-4204626
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.)

______________

200 Oceangate, Suite 100, Long Beach, California 90802
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (562) 435-3666
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:

Title of each class | Trading Symbol(s) | Name of each exchange on which registered
Common Stock, $0.001 Par Value | MOH | New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company | ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section13(a) of the Exchange Act. | ☐

Item 7.01. Regulation FD Disclosure.
On Thursday, January 14, 2021, the Company’s management held a virtual presentation and question and answer session at the 39th Annual J.P. Morgan Healthcare Conference. A copy of the Company’s complete slide presentation is included as Exhibit 99.1 to this report. An audio and slide replay of the Company’s presentation will be available for 30 days from the date of the presentation on the Company’s website www.molinahealthcare.com.
Note: The information furnished herewith pursuant to Item 7.01 of this current report on Form 8-K shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits:
Exhibit

No. | Description
99.1 | Slide presentation in connection with the Company’s presentation at the 39th Annual J.P. Morgan Healthcare Conference on January 14, 2021.
104 | Cover page information from Molina Healthcare, Inc.’s Current Report on Form 8-K filed on January 14, 2021 formatted in iXBRL (Inline Extensible Business Reporting Language)

SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

|  | MOLINA HEALTHCARE, INC. |
Date: January 14, 2021 | By: | /s/ Jeff D. Barlow |
|  | Jeff D. Barlow, |
|  | Chief Legal Officer and Secretary |